Skip to content

APOTHEEK AERNOUTS

Active
Private limited companyfounded 1998active for 27 yearsStatiestraat 6, 2340 Beerse, BelgiumKBO/BCE: BE 0464.543.688
Summary

APOTHEEK AERNOUTS has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €705,434 and a net result of €53,096. Equity has been growing by about 11% per year since 2019. Its solvency ranks better than 85% of 633 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 05-11-1998 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 31-03-2026
Establishment unit
2.089.241.923 2340 Beerse, since 17-11-1998
Financial year end
31 March
Peppol
Reachable since 27-11-2025

Board and ownership

Board
Shareholders

Financial position

97 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-03-2026
Gross margin
€233,229
▼ 2.4%
Turnover
≈ €1.1m
estimated
Profit
€53,096
▼ 3.2%
Equity
€705,434
▲ 7.8%
Total assets
€1.0m
▲ 9.3%
Employees on 31-03-2026
3
▼ 25.0%
Score breakdownlowers riskLiquidity: current ratio 3.18, cash €593,815Equity €705,434 (70.3% of total assets)Founded in 1998Size: 2.6 FTE, total assets €1.0mShow the evidence

Checked score

Score 2026
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 72% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2025
Strong
Solvency 95-1
equity 70.3% of total assets
Liquidity 88-1
short-term debt 29.3% · cash 59.2%
Profitability 75-1
return on assets 5.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.18 (3.12 in 2025), above the usual 1.5. Short-term debt is 29.3% and cash 59.2% of total assets. 29.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 81% of them on solvency, 90% on liquidity, 62% on profitability and 57% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 3.18, cash €593,815
NBB · annual accounts
lowers risk · Equity €705,434 (70.3% of total assets)
NBB · annual accounts
lowers risk · Founded in 1998
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: 2.6 FTE, total assets €1.0m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 01-10-2026, 30 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
30 days early
2025
38 days early
2024
28 days early
2023
33 days early
2022
42 days early
2021
45 days early
2020
32 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 35 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 28 September (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 85% of companies in retail tradesector median 32.6% · 633 companies 70.3% View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2026: €53,096 8 years View

Recent changes

  1. · Gazette deed Resignation: AERNOUTS Inge (director)Appointment: AERNOUTS Inge (director)
All 13 events

Comparable companies

These companies have the same main activity as APOTHEEK AERNOUTS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €819,000 and €1.2m, founded between 1997 and 1999.

CompanyTotal assetsGross margin
APOTHEEK AERNOUTS Beerse€1.0m€0.2m
HOLSBEEK DEURNE Antwerpen€0.9m€0.2m
Apotheek Desrumaux Mortsel€0.9m€0.3m
APOTHEEK WELLENS Herentals€1.2m€0.3m
Apotheek Melkmarkt Antwerpen€1.1m€0.2m
APOTHEEK TWEE NETEN Lier€0.8m€0.3m
Apotheek Bossers Boortmeerbeek€0.9m€0.2m
Full comparison

Key facts about APOTHEEK AERNOUTS

What is the company number of APOTHEEK AERNOUTS?
The company number of APOTHEEK AERNOUTS is 0464.543.688. The VAT number is the same number with BE in front: BE 0464.543.688.
Where is APOTHEEK AERNOUTS based?
The registered office is at Statiestraat 6, 2340 Beerse.Company details
What does APOTHEEK AERNOUTS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK AERNOUTS?
The legal form of APOTHEEK AERNOUTS is Private limited company (BV).
When was APOTHEEK AERNOUTS founded?
APOTHEEK AERNOUTS was founded on 05-11-1998.
Is APOTHEEK AERNOUTS still active?
Yes, APOTHEEK AERNOUTS is an active enterprise in the KBO register.
How many employees does APOTHEEK AERNOUTS have?
APOTHEEK AERNOUTS had an average of 2.6 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK AERNOUTS fall under?
In its 31-03-2026 annual accounts, APOTHEEK AERNOUTS states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of APOTHEEK AERNOUTS?
The turnover in financial year 2026 is ≈ €1.1m. This figure is estimated from the gross margin of €233,229 and 51 comparable companies (NACE 477). It probably lies between €740,000 and €2.1m.
Is APOTHEEK AERNOUTS profitable?
In financial year 2026, APOTHEEK AERNOUTS made a profit of €53,096.
Where can I find the annual accounts of APOTHEEK AERNOUTS?
APOTHEEK AERNOUTS filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of APOTHEEK AERNOUTS due?
APOTHEEK AERNOUTS must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.